跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BOOSTRIX-IPV 0.5 mL injection syringe
Approved
STANDARD
BOOSTRIX-IPV 0.5 mL injection syringe
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
166c78b28cd33b79
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
166c78b28cd33b79
Product Name
BOOSTRIX-IPV 0.5 mL injection syringe
Artg Id
96137
Artg Name
BOOSTRIX-IPV 0.5 mL injection syringe
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2004-07-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0fdd98cd23738f3e416ab2a04a30db47.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/06a0c9f8356d499fb5558d7cd636539e.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
166c78b28cd33b79
Type
Standard
Back to TGA Approvals
BOOSTRIX-IPV 0.5 mL injection syringe - TGA Drug Approval Details